精神分裂症复发预防的家庭干预:系统综述与网络Meta分析
该系统综述与网络Meta分析纳入90项随机对照试验共10340例精神分裂症谱系患者,比较11种家庭干预模型预防复发的疗效。除危机导向干预和两次及以下的家庭心理教育外,所有干预在12个月主要时间点均较常规治疗显著降低复发率,单纯家庭心理教育效果最优。
要点
- 除危机导向干预和两次及以下的家庭心理教育外,所有家庭干预模型在12个月时均较常规治疗显著降低复发率。
- 单纯家庭心理教育优于更复杂的模型,与常规治疗相比OR为0·18(95%CI 0·12-0·27)。
- 作者认为在存在经济限制的情况下应实施单纯家庭心理教育。
核心结论
- 几乎所有家庭干预模型均能有效预防精神分裂症复发,单纯家庭心理教育优于更复杂的模型。
- 作者认为在存在经济限制的情况下应实施单纯家庭心理教育。
研究设计与样本
- 系统综述与网络Meta分析,检索EMBASE、MEDLINE、PsycINFO、BIOSIS、CENTRAL、ClinicalTrials.gov和WHO国际临床试验注册平台至2020年1月20日及PubMed至2021年7月15日。
- 纳入至少80%患者为精神分裂症谱系障碍的盲法或开放标签随机对照试验,排除所有患者均为急性病、合并躯体或精神疾病、或前驱期/精神病风险的研究。
- 最终纳入90项随机对照试验共10340例参与者(注明性别的为3579例女性和5632例男性;中位年龄31岁,范围14-65岁),比较11种家庭干预模型。
主要发现
- 在12个月主要时间点,除危机导向干预和两次及以下的家庭心理教育外,所有干预较常规治疗均显著降低复发率。
- 与常规治疗相比,单纯家庭心理教育的OR为0·18(95%CI 0·12-0·27),涉及家庭成员的小区干预OR为0·63(95%CI 0·42-0·94)。
- 结果在多种敏感性和亚组分析中稳健,不同比较的置信度从中等到极低不等。
关键数值与推荐
- 主要结局为复发,采用操作性标准、精神科住院或临床判断测量。
- 采用频率学随机效应网络Meta分析计算OR(二分类结局)或标准化均数差(连续结局)及95%CI。
临床怎么用
- 作者认为在存在经济限制的情况下应实施单纯家庭心理教育。
局限性
- 不同比较的置信度从中等到极低不等。
- 种族数据不可获得。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Family interventions are efficacious for relapse prevention in schizophrenia. Multiple different models have been developed. We aimed to compare the efficacy, acceptability, and tolerability of family interventions for relapse prevention in schizophrenia. METHODS: In this systematic review and network meta-analysis, we searched for randomised controlled trials that investigated family intervention models aimed at preventing relapse in patients with schizophrenia. We searched EMBASE, MEDLINE, PsycINFO, BIOSIS, CENTRAL, ClinicalTrials.gov, and WHO International Clinical Trials Registry Platform up to Jan 20, 2020 and PubMed up to July 15, 2021. We included blinded and open-label randomised controlled trials in which at least 80% of patients had schizophrenia spectrum disorders. We excluded studies in which all patients were acutely ill, had a concurrent medical or psychiatric disorder, or were prodromal or "at risk of psychosis". Study selection and data extraction were done by two independent reviewers. Data were extracted about overall, positive, negative, and depressive symptoms of schizophrenia, quality of life, adherence, overall functioning, family burden, expressed emotion, and discontinuations due to inefficacy. The primary outcome was relapse, measured with operationalised criteria, psychiatric hospital admissions, or clinical judgement. We did a frequentist, random-effects, network meta-analysis to calculate odds ratios ([ORs]; dichotomous outcomes) or standardised mean differences (continuous outcomes) with 95% CIs. The study protocol was registered with PROSPERO, CRD42020169951. FINDINGS: We identified 28 395 studies through the database search and 334 from references of previous studies. We compared 11 family intervention models tested on a total of 90 randomised controlled trials with 10 340 participants (3579 females and 5632 males with sex indicated; median age 31 years [range 14-65]) in the network meta-analysis. Ethnicity data were not available. All interventions, with the exception of crisis-oriented interventions and family psychoeducation with two sessions or fewer, reduced the relapse rate significantly when compared with treatment as usual at the primary timepoint of 12 months. ORs compared with treatment as usual ranged from 0·18 (95% CI 0·12-0·27) for family psychoeducation alone to 0·63 (0·42-0·94) for community-based interventions involving family members. The results were robust in various sensitivity and subgroup analyses. The confidence in the estimates ranged from moderate to very low for different comparisons. INTERPRETATION: Almost all family intervention models were efficacious in preventing relapse in schizophrenia. Family psychoeducation alone, without behavioural or skills training, was superior to the more complex models. Our results suggest that in contexts where there are financial constraints, family psychoeducation alone should be implemented. FUNDING: German Ministry for Education and Research.
引用
- Rodolico A, Bighelli I, Avanzato C, et al. Family interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2022. PMID: 35093198. doi:10.1016/S2215-0366(21)00437-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。